Tuberculosis: Difference between revisions

	Tuberculosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Tuberculosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Children
HIV Coinfection
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Special Conditions
Drug-resistant
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Tuberculosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Tuberculosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Tuberculosis
CDC on Tuberculosis
Tuberculosis in the news
Blogs on Tuberculosis
Directions to Hospitals Treating Tuberculosis
Risk calculators and risk factors for Tuberculosis

Revision as of 21:50, 14 October 2016

For patient information, click here.

This page is about clinical aspects of the disease. For microbiologic aspects of the causative organism(s), see Mycobacterium tuberculosis.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maheep Singh Sangha, M.B.B.S.; Somal Khan; João André Alves Silva, M.D. [2]; Alejandro Lemor, M.D. [3]; Ammu Susheela, M.D. [4]; Tarek Nafee, M.D. [5]

Synonyms and keywords: TB, Tb, tb

@@ Line 16: / Line 16: @@
 ==Causes==
-[[Mycobacterium tuberculosis]]
-===Drug Side Effect===
-*[[Ceritinib]]
-*[[Dexamethasone]]
-*[[Golimumab]]
-*[[Ruxolitinib]]
-*[[Triamcinolone]]
-*[[Vedolizumab]]
 ==[[Tuberculosis differential diagnosis|Differentiating Tuberculosis from other Diseases]]==